🔴 Tiziana Life Sciences is trading 5.6% down in pre-market with no clear company-specific catalyst identified

Tiziana Life Sciences is trading 5.6% down at $0.91 after falling from the September 10 close of $0.96, with no clear company-specific catalyst identified.

• No company-specific announcement, earnings release, regulatory event, or analyst action dated September 11, 2026 was identified.
• The latest listed release was its August 24 ALS Nexus presentation announcement; the broader market is firmer pre-market, so macro sentiment does not clearly explain the isolated decline.
• Volume and activity details were unavailable.